ISOLATION OF A NOVEL GENE UNDERLYING BATTEN-DISEASE, CLN3

被引:490
作者
LERNER, TJ
BOUSTANY, RMN
ANDERSON, JW
DARIGO, KL
SCHLUMPF, K
BUCKLER, AJ
GUSELLA, JF
HAINES, JL
KREMMIDIOTIS, G
LENSINK, IL
SUTHERLAND, GR
CALLEN, DF
TASCHNER, PEM
DEVOS, N
VANOMMEN, GJB
BREUNING, MH
DOGGETT, NA
MEINCKE, LJ
LIU, ZY
GOODWIN, LA
TESMER, JG
MITCHISON, HM
ORAWE, AM
MUNROE, PB
JARVELA, IE
GARDINER, RM
MOLE, SE
机构
[1] HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02114 USA
[2] HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02114 USA
[3] DUKE UNIV, MED CTR, DIV PEDIAT NEUROL, DURHAM, NC 27710 USA
[4] WOMENS & CHILDRENS HOSP, DEPT CYTOGENET & MOLEC GENET, ADELAIDE, SA 5006, AUSTRALIA
[5] LEIDEN UNIV, DEPT HUMAN GENET, 2333 AL LEIDEN, NETHERLANDS
[6] ERASMUS UNIV ROTTERDAM, DEPT CLIN GENET, 3015 GE ROTTERDAM, NETHERLANDS
[7] LOS ALAMOS NATL LAB, DIV LIFE SCI, LOS ALAMOS, NM 87545 USA
[8] LOS ALAMOS NATL LAB, CTR HUMAN GENOME STUDIES, LOS ALAMOS, NM 87545 USA
[9] UCL, SCH MED, RAYNE INST, DEPT PEDIAT, LONDON WC1E 6JJ, ENGLAND
基金
英国医学研究理事会; 美国能源部; 英国惠康基金; 美国国家卫生研究院;
关键词
D O I
10.1016/0092-8674(95)90274-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Batten disease (also known as juvenile neuronal ceroid lipofuscinosis) is a recessively inherited neurodegenerative disorder of childhood characterized by progressive loss of vision, seizures, and psychomotor disturbances. The Batten disease gene, CLN3, maps to chromosome 16p12.1. The so-called 56 chromosome haplotype defined by alleles at the D16S299 and D16S298 loci is shared by 73% of Batten disease chromosomes. Exon amplification of a cosmid containing D76S298 has yielded a candidate gene that is disrupted by a 1 kb genomic deletion in all patients carrying the 56 chromosome. Two separate deletions and a point mutation altering a splice site in three unrelated families have confirmed the candidate as the CLN3 gene. The disease gene encodes a novel 438 amino acid protein of unknown function.
引用
收藏
页码:949 / 957
页数:9
相关论文
共 50 条
  • [41] Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease
    Centa, Jessica L.
    Jodelka, Francine M.
    Hinrich, Anthony J.
    Johnson, Tyler B.
    Ochaba, Joseph
    Jackson, Michaela
    Duelli, Dominik M.
    Weimer, Jill M.
    Rigo, Frank
    Hastings, Michelle L.
    [J]. NATURE MEDICINE, 2020, 26 (09) : 1444 - 1451
  • [42] The CLN3 Disease Staging System: A new tool for clinical research in Batten disease
    Masten, Margaux C.
    Williams, Justin D.
    Vermilion, Jennifer
    Adams, Heather R.
    Vierhile, Amy
    Collins, Alyssa
    Marshall, Frederick J.
    Augustine, Erika F.
    Mink, Jonathan W.
    [J]. NEUROLOGY, 2020, 94 (23) : E2436 - E2440
  • [43] Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
    Järvelä, I
    Lehtovirta, M
    Tikkanen, R
    Kyttälä, A
    Jalanko, A
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (06) : 1091 - 1098
  • [44] Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease
    Jessica L. Centa
    Francine M. Jodelka
    Anthony J. Hinrich
    Tyler B. Johnson
    Joseph Ochaba
    Michaela Jackson
    Dominik M. Duelli
    Jill M. Weimer
    Frank Rigo
    Michelle L. Hastings
    [J]. Nature Medicine, 2020, 26 : 1444 - 1451
  • [45] Splice-Switching Antisense Oligonucleotides for the Treatment of CLN3 Batten Disease
    Centa, Jessica L.
    Jodelka, Francine M.
    Hinrich, Anthony J.
    Johnson, Tyler B.
    Rigo, Frank
    Weimer, Jill M.
    Hastings, Michelle L.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 303 - 303
  • [46] Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease
    Morison, Lottie D.
    Whiteman, Ineka T.
    Vogel, Adam P.
    Tilbrook, Lisa
    Fahey, Michael C.
    Braden, Ruth
    Bredebusch, Joanna
    Hildebrand, Michael S.
    Scheffer, Ingrid E.
    Morgan, Angela T.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (01)
  • [47] Caspase 1 activity influences juvenile Batten disease (CLN3) pathogenesis
    Burkovetskaya, Maria
    Bosch, Megan E.
    Karpuk, Nikolay
    Fallet, Rachel
    Kielian, Tammy
    [J]. JOURNAL OF NEUROCHEMISTRY, 2019, 148 (05) : 652 - 668
  • [48] Efficacy of Phosphodiesterase-4 Inhibitors in Juvenile Batten Disease (CLN3)
    Aldrich, Amy
    Bosch, Megan E.
    Fallet, Rachel
    Odvody, Jessica
    Burkovetskaya, Maria
    Rao, Kakulavarapu V. Rama
    Cooper, Jonathan D.
    Drack, Arlene V.
    Kielian, Tammy
    [J]. ANNALS OF NEUROLOGY, 2016, 80 (06) : 909 - 923
  • [49] GENETIC-MAPPING OF THE BATTEN-DISEASE LOCUS (CLN3) TO THE INTERVAL D165288-D165383 BY ANALYSIS OF HAPLOTYPES AND ALLELIC ASSOCIATION
    MITCHISON, HM
    TASCHNER, PEM
    ORAWE, AM
    DEVOS, N
    PHILLIPS, HA
    THOMPSON, AD
    KOZMAN, HM
    HAINES, JL
    SCHLUMPF, K
    DARIGO, K
    BOUSTANY, RMN
    CALLEN, DF
    BREUNING, MH
    GARDINER, RM
    MOLE, SE
    LERNER, TJ
    [J]. GENOMICS, 1994, 22 (02) : 465 - 468
  • [50] Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease
    Holthaus, Sophia-Martha Kleine
    Aristorena, Mikel
    Maswood, Ryea
    Semenyuk, Olha
    Hoke, Justin
    Hare, Aura
    Smith, Alexander J.
    Mole, Sara E.
    Ali, Robin R.
    [J]. HUMAN GENE THERAPY, 2020, 31 (13-14) : 709 - 718